THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 114 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 8,511,350 | $72,176,248 | 9.12% |
| Newtyn Management, LLC | 2,124,703 | $18,017,481 | 3.38% |
| Irenic Capital Management LP | 2,760,948 | $23,412,839 | 2.86% |
| Weiss Asset Management LP | 7,457,060 | $63,235,869 | 2.39% |
| Oasis Management Co Ltd. | 1,157,965 | $9,819,543 | 2.21% |
| Park West Asset Management LLC | 1,700,000 | $14,416,000 | 1.06% |
| Baupost Group | 4,200,021 | $35,616 | 0.98% |
| Camber Capital Management LP | 1,000,000 | $8,480 | 0.24% |
| Virtus ETF Advisers LLC | 38,386 | $325,513 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 204,089 | $1,731 | 0.12% |